IL2 and non-small cell lung carcinoma: Usually, NSCLC patients are accompanied by elevated TNF-α, IL-2, and CRP levels (34) and tend to have a reduction in Tregs, lymphocytes, T cells, and CD3+CD4+ T cells (34).